Table 3.

The proportion of patients with zero qualifying or all relapses (overall or severe) in the CP 3.5 mg/kg group at Year 4 in CLARITY Extension.

Type of relapse	Patients with zero relapses at Year 4, n (%)
	CP 3.5 mg/kg group N = 98
Qualifying relapses
Overall relapses	83 (84.7)
Relapses requiring steroid treatment	85 (86.7)
Relapses leading to hospitalisation	92 (93.9)
All relapses
Overall relapses	72 (73.5)
Relapses requiring steroid treatment	77 (78.6)
Relapses leading to hospitalisation	86 (87.8)

CP 3.5 mg/kg: cladribine tablets 3.5 mg/kg in CLARITY followed by placebo in CLARITY Extension.